# Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis

> **NCT00043303** · PHASE2 · COMPLETED · sponsor: **InterMune** · enrollment: 502 (actual)

## Conditions studied

- Liver Fibrosis
- Cirrhosis

## Interventions

- **DRUG:** interferon gamma-1b

## Key facts

- **NCT ID:** NCT00043303
- **Lead sponsor:** InterMune
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** —
- **Final completion:** 2003-11
- **Target enrollment:** 502 (ACTUAL)
- **Last updated:** 2007-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043303, "Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00043303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*